BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27390544)

  • 1. Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis.
    Ahn JH; Yu JS; Cho ES; Chung JJ; Kim JH; Kim KW
    Korean J Radiol; 2016; 17(4):533-40. PubMed ID: 27390544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.
    Catalano OA; Choy G; Zhu A; Hahn PF; Sahani DV
    Radiology; 2010 Jan; 254(1):154-62. PubMed ID: 20032150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients.
    Sandrasegaran K; Tahir B; Nutakki K; Akisik FM; Bodanapally U; Tann M; Chalasani N
    AJR Am J Roentgenol; 2013 Dec; 201(6):1211-9. PubMed ID: 24261359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performances of intravoxel incoherent motion and conventional diffusion-weighted imaging in the differential diagnosis of benign and malignant portal vein thrombus.
    Aumann EK; Server S; Koyuncu Sokmen B; Oz A; Namal E; Gurcan NI; Balci NC; Tokat Y
    Abdom Radiol (NY); 2018 Sep; 43(9):2270-2276. PubMed ID: 29411058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions.
    Jeon JY; Chung HW; Lee MH; Lee SH; Shin MJ
    Br J Radiol; 2016; 89(1060):20150929. PubMed ID: 26892266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.
    Tarantino L; Ambrosino P; Di Minno MN
    World J Gastroenterol; 2015 Aug; 21(32):9457-60. PubMed ID: 26327753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: Value of post contrast imaging with subtraction.
    Gawande R; Jalaeian H; Niendorf E; Olgun D; Krystosek L; Rubin N; Spilseth B
    Eur J Radiol; 2019 Sep; 118():88-95. PubMed ID: 31439264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma: Diagnostic Accuracy of Gadoxetic Acid-enhanced MR Imaging.
    Kim JH; Lee JM; Yoon JH; Lee DH; Lee KB; Han JK; Choi BI
    Radiology; 2016 Jun; 279(3):773-83. PubMed ID: 26780538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Role of Contrast-enhanced Ultrasound in the Discrimination of Malignant Portal Vein Thrombosis in Patients With Hepatocellular Carcinoma.
    Kwon JH; Yoo SH; Nam SW; Lee YJ; Shin YR
    Anticancer Res; 2020 Aug; 40(8):4351-4363. PubMed ID: 32727763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma.
    Ascenti G; Sofia C; Mazziotti S; Silipigni S; D'Angelo T; Pergolizzi S; Scribano E
    Clin Radiol; 2016 Sep; 71(9):938.e1-9. PubMed ID: 27241866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Portal Vein Thrombosis (Neoplastic Versus Bland) on CT Images Using Software-Based Texture Analysis and Thrombus Density (Hounsfield Units).
    Canellas R; Mehrkhani F; Patino M; Kambadakone A; Sahani D
    AJR Am J Roentgenol; 2016 Nov; 207(5):W81-W87. PubMed ID: 27490095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
    Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
    Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign and malignant portal vein thrombosis: differentiation by CT characteristics.
    Tublin ME; Dodd GD; Baron RL
    AJR Am J Roentgenol; 1997 Mar; 168(3):719-23. PubMed ID: 9057522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
    Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
    J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
    Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
    Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules.
    Jia Y; Cai H; Wang M; Luo Y; Xu L; Dong Z; Yan X; Li ZP; Feng ST
    Contrast Media Mol Imaging; 2019; 2019():2030147. PubMed ID: 31396023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of susceptibility-weighted imaging in differentiating benign from malignant portal vein thrombosis.
    Huang C; Xiao X; Guo M; Hu X; Liu C; Wang J; Zhang H; Li X; Cai P
    Quant Imaging Med Surg; 2023 Apr; 13(4):2688-2696. PubMed ID: 37064354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT.
    Agarwal KK; Shah D; Shah N; Mayank M
    Clin Nucl Med; 2017 Nov; 42(11):e472-e474. PubMed ID: 28922192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.